OMNY Health Launches Data Platform Designed to Power AI-Driven Health Tech Companies
July 02 2024 - 9:00AM
Business Wire
OMNY Health Aims to Help AI Companies,
including QuantHealth and ArisGlobal, Develop Better Solutions to
Drive Clinical Trial Success, Patient Safety, and More
OMNY Health, the leading healthcare ecosystem
known for facilitating compliant cross-industry data sharing
launched its platform designed to power AI-driven health technology
companies, further cementing the company’s commitment to
democratizing healthcare data. QuantHealth and ArisGlobal are just
two of OMNY’s newest partners to leverage this new platform to
power their organizational AI-driven needs. OMNY Health’s data
network uniquely addresses Generative AI’s need for large
de-identified structured and unstructured electronic health record
(EHR) data sets across diverse provider and patient populations,
further underscoring the platform as delivering the data
infrastructure and rails for provider organizations to collaborate
and fuel the development and use of effective AI solutions for
advancing healthcare.
“Our mission is to free data from silos, allowing it to be
shared, analyzed, and morphed into life-saving treatments and
better care for patients,” said Mitesh Rao, CEO, OMNY Health. "Life
science organizations and providers often struggle with time and
budget constraints that hinder their ability to learn from their
data. Our work powering AI-driven platforms can unblock this
process by partnering with AI developers with data and tools to
accelerate breakthrough therapies and monitor new therapies for
safety signals to ensure patient populations remain safe.”
Two of OMNY Health’s AI-driven partners being effectively
powered by the platform’s data to foster new opportunities for
advancing healthcare include QuantHealth, the leading AI-driven
clinical trial design company, and ArisGlobal, a technology company
at the forefront of life sciences and creator of LifeSphere®.
QuantHealth’s AI technology, trained on a dataset of 350 million
patients, enhances clinical trial timelines, mitigates trial risks,
and identifies populations likely to respond to treatments. OMNY’s
collaboration will help QuantHealth's pharmaceutical partners
expedite drug development through simulated clinical trials,
utilizing real-world evidence to predict clinical trial outcomes,
drug efficacy, and patient responses.
“Biotech is entering a vibrant part of life sciences history,”
said Omri Matalon, VP Clinical Data Science and Head of R&D
Operations at QuantHealth. "This partnership furthers our
commitment to quality data and access for our life sciences
partners. By integrating diverse EHRs into organized, de-identified
research data products, we can address disparities in clinical
trials and close significant demographic information gaps in drug
discovery and development.”
OMNY’s partnership with ArisGlobal, a leader in
pharmacovigilance, safety monitoring, and reporting systems, will
transform safety signal validation and pave the way for
comprehensive, proactive signal detection.
“Up to 95% of adverse event cases go unreported today, while
processing ICSRs can be time consuming, and analysis of medical
literature and online forums is slow and inefficient,” said
Ann-Marie Orange, CIO and Global Head of R&D at ArisGlobal.
“Combining LifeSphere products with comprehensive real-time RWD
addresses these challenges head-on. By leveraging advanced
technology and insights from extensive RWD, we are reshaping drug
discovery and development.”
These partnerships demonstrate OMNY Health's commitment to
AI-enabled healthcare improvement through acceleration of diverse
participation in clinical trials and the support of research
programs that aim to save lives and improve patient outcomes. To
learn more about how OMNY Health is transforming lives and driving
patient care by connecting providers and life sciences companies
through data, visit https://omnyhealth.com/.
About OMNY Health
OMNY Health™ is a national data ecosystem connecting the world
of healthcare to fuel partnerships that improve clinical outcomes
and drive patient care. OMNY’s dynamic partnerships with specialty
health networks, healthcare systems, academic medical centers, and
integrated delivery networks span all fifty states and cover over
75 million patient lives. The company’s comprehensive data layer
powers health tech companies to drive the next generation of
innovation. The platform serves as a centralized resource for life
sciences and healthcare provider groups to facilitate
mutually-beneficial data sharing and research collaboration at
scale, fueling innovation where patients need it the most. OMNY
Health’s data ecosystem now reflects more than seven years of
historical data encompassing more than 2 billion clinical notes
from 300,000+ providers across 200+ specialties - and is growing.
For more information, visit www.omnyhealth.com.
About ArisGlobal
ArisGlobal, an innovative life sciences technology company and
creator of LifeSphere®, is transforming the way today’s most
successful life sciences companies develop breakthroughs and bring
new products to market. Headquartered in the United States,
ArisGlobal has regional offices in Europe, India, Japan, and China.
For more updates, follow ArisGlobal on LinkedIn or visit
https://www.arisglobal.com/.
About QuantHealth
90% of drugs fail the clinical stage, representing a direct $45B
annual waste to pharma companies. To address this challenge at its
core, QuantHealth's Clinical-Simulator predicts how each patient in
a clinical trial will respond to treatment, allowing trial design
teams to predict how an entire clinical trial will play out and
adapt accordingly. Based on its novel AI engine and a vast dataset
of 350m patients and over 700K therapeutics, QuantHealth's
simulator can predict clinical trial results with high accuracy,
allowing users to answer mission-critical questions such as trial
go/no-go, cohort optimization, drug repurposing, and more.
QuantHealth was founded by healthcare experts who led commercial,
product, and data science at various leading companies in the US
and Israel. QuantHealth is backed by expert Life-Science investors
in the US, Europe, and Israel and is supported by an advisory board
of physicians and scientists from leading academic institutions. To
learn more, visit https://quanthealth.ai/.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240702311911/en/
SolComms omnyhealth@solcomms.co